R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
On March 18, 2026, the Food and Drug Administration (FDA) issued draft guidance entitled “General Considerations for the Use of New ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing ...
As the FDA released its draft guidance, the NIH said it will invest $150 million in human-based research to develop the tools ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results